Evidence map›Paper›PMID 41623445›Full record

ArticleJournal of research in medical sciences : the official journal of Isfahan University of Medical Sciences2025

Radiofrequency radiation from mobile phones and the risk of breast cancer: A multicenter case-control study with an additional suspected comparison group.

Sedigheh Tahmasebi, S M J Mortazavi, Masumeh Pourghayoomi, Peyman Sheikhzadeh, James S Welsh, Fatemeh Seif, Mohamed Reza Bayatiani, Samaneh Nematollahi, Pooya Zohdparast, Farnoosh Khoskhati and 22 more

Abstract read
In one paragraph

Article in Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Sedigheh TahmasebiBreast Cancer Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
S M J MortazaviIonizing and Non-Ionizing Radiation Protection Research Center (INIRPRC), Shiraz University of Medical Sciences, Shiraz, Iran.
Masumeh PourghayoomiDepartment of Nuclear Medicine, IKHC, Tehran University of Medical Sciences, Tehran, Iran.
Peyman SheikhzadehDepartment of Nuclear Medicine, IKHC, Tehran University of Medical Sciences, Tehran, Iran.
James S WelshDepartment of Radiation Oncology, Edward Hines Jr VA Hospital, Hines, IL, United States.
Fatemeh SeifDepartment of Radiotherapy and Medical Physics, Faculty of Para Medicine, Arak University of Medical Sciences and Khansari Hospital, Arak, Iran.
Mohamed Reza BayatianiDepartment of Radiotherapy and Medical Physics, Faculty of Para Medicine, Arak University of Medical Sciences and Khansari Hospital, Arak, Iran.
Samaneh NematollahiNoncommunicable Diseases Research Center, Bam University of Medical Sciences, Bam, Iran.
Pooya ZohdparastPetroleum Department, Institute of Petroleum Engineering, School of Chemical Engineering, College of Engineering, University of Tehran, Iran.
Farnoosh KhoskhatiDepartment of Medical Physics, School of Medicine, Shiraz University of Medical Science, Shiraz, Iran.
Zahra GhahramaniDepartment of Radiology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Farzaneh AllahveisiDepartment of Radiotherapy and Nuclear Medicine, Faculty of Paramedicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Pedram FadaviDepartment of Radiation Oncology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Ali Jomeh ZadehDepartment of Medical Physics, School of Medicine, Kerman University of Medical Science, Kerman, Iran.
Saeed Rajaee NejadDepartment of Radiation Oncology, School of Medicine, Kerman University of Medical Science, Kerman, Iran.
Fatemeh ZakerIonizing and Non-Ionizing Radiation Protection Research Center (INIRPRC), Shiraz University of Medical Sciences, Shiraz, Iran.
Manijeh BeigiDepartment of Radiation Oncology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Sakineh BagherzadehDepartment of Medical Physics, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
Mohsen KhosroabadiDepartment of Medical Physics, North Khorasan University of Medical Sciences, Bojnurd, Iran.
Mehran YarahmadiRadiotherapy Center of Tohid Hospital, Sanandaj, Iran.
Masoud HaghaniIonizing and Non-Ionizing Radiation Protection Research Center (INIRPRC), Shiraz University of Medical Sciences, Shiraz, Iran.
Safoora NikzadDepartment of Medical Physics, School of Medicine, Isfahan University of Medical Science, Isfahan, Iran.
Najmeh BahaeddiniDepartment of Radiology, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.
Maryam ArshadiDepartment of Medical Physics and Engineering, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Shole RahimiNursing Department, Nursing and Midwifery School, Shiraz University of Medical Sciences, Shiraz, Iran.
Jamshid EslamiNursing Department, Nursing and Midwifery School, Shiraz University of Medical Sciences, Shiraz, Iran.
Amirali FallahDepartment of Medical Physics and Engineering, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Mojtaba SafdariSchool of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Fatemeh MakarempourDepartment of Medical Physics and Engineering, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Mina AmirinejadStudent Committee, Ionizing and Non-Ionizing Radiation Protection Research Center (INIRPRC), Shiraz University of Medical Sciences, Shiraz, Iran.
Alireza MortazaviSchool of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Seyed Ali Reza MortazaviSchool of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The rapid global increase in mobile phone use has raised concerns about the potential long-term health effects of radiofrequency electromagnetic fields. While most studies have focused on brain tumors, evidence regarding breast cancer remains limited. The objective of the study is to examine the association between mobile phone use and breast cancer risk among women in Iran. Materials and Methods: In this multicenter case-control study, 226 women were recruited from diagnostic, mammography, and radiotherapy centers across Iran and classified as controls (no history of breast cancer, Results: In fully adjusted models, women reporting more than 60 min of daily mobile phone conversations had higher odds of confirmed breast cancer (odds ratio [OR] = 3.49, 95% confidence interval [CI]: 1.02-11.97) and suspected status (OR = 10.84, 95% CI: 2.29-51.41) compared with those using phones <10 min daily. Longer screen time (>4 h/day), later age at menarche, lower education level, and exposure to environmental pollutants were also associated with increased odds. Conclusion: Prolonged mobile phone use was associated with higher odds of breast cancer, but this does not imply causation. Given self-reported exposures and potential residual confounding, findings should be interpreted cautiously. Larger prospective studies with objective exposure assessment are warranted.

Indexed as

Breast cancerelectromagnetic fieldsmobile phonesprolonged phone useradiofrequency radiation

Identifiers

PMID41623445
PMCPMC12860463

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.